companydata.dkcompanydata.dk

Reapplix A/S: Financial statements 2023

CVR: 31261570

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Reapplix A/S (CVR 31261570) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 1,818,000 and a net result of DKK -43,068,000 compared with DKK -45,019,000 the year before. That is a decrease of 58.5% compared with the year before. The profit margin was -2,369%. Equity in the 2023 report amounted to DKK 57,524,000. The solvency ratio was 92.9%. The company had 23 employees in the financial year.

Revenue
DKK 1,818,000
Gross Profit
DKK -3,310,000
Profit/Loss
DKK -43,068,000
Equity
DKK 57,524,000
Total Assets
DKK 61,949,000
Employees
23

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20231.8M-3.3M-43.1M57.5M23
20224.4M2.9M-45M26M-
20211.6M940K-31.4M72.7M-
2020733K437K-35.4M43.5M-
2019656K320K-89.6M-18.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Jørgen Ulrik Vejlsgaard joins the board of Reapplix A/SDec 13, 2023

As of December 13, 2023, Jørgen Ulrik Vejlsgaard has joined the board of directors of Reapplix A/S.

Richard Twomey joins the board of Reapplix A/SDec 13, 2023

As of December 13, 2023, Richard Twomey has joined the board of directors of Reapplix A/S.

Jørgen Ulrik Vejlsgaard leaves the board of Reapplix A/SDec 12, 2023

As of December 12, 2023, Jørgen Ulrik Vejlsgaard has left the board of directors of Reapplix A/S.

Richard Twomey leaves the board of Reapplix A/SDec 12, 2023

As of December 12, 2023, Richard Twomey has left the board of directors of Reapplix A/S.

North-East Health Care Holding ApS registered as owner of Reapplix A/SSep 30, 2023

As of September 30, 2023, North-East Health Care Holding ApS is registered as an owner of Reapplix A/S with an ownership share of 10%.

Reapplix A/S: The 2022 annual report is outJun 29, 2023

Reapplix A/S has published its annual report for 2022. Revenue came to DKK 4,384,000, and the net result was DKK -45,019,000.

Ulrik Spork leaves the board of Reapplix A/SJun 26, 2023

As of June 26, 2023, Ulrik Spork has left the board of directors of Reapplix A/S.

Cyrille Yann Nicolas Petit leaves the board of Reapplix A/SJun 26, 2023

As of June 26, 2023, Cyrille Yann Nicolas Petit has left the board of directors of Reapplix A/S.

Rasmus Lundquist steps down as underdirektør of Reapplix A/SMay 31, 2023

As of May 31, 2023, Rasmus Lundquist has stepped down as underdirektør of Reapplix A/S.

Bo Jesper Hansen registered as owner of Reapplix A/SMay 23, 2023

As of May 23, 2023, Bo Jesper Hansen is registered as an owner of Reapplix A/S with an ownership share of 5%.

About Reapplix A/S

Reapplix A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named REAPPLIX ApS. The management consists of Morten Have-Rasmussen. The board consists of Klaus Eldrup-Jørgensen (chair), Bo Jesper Hansen, Jørgen Ulrik Vejlsgaard and Kira Paniagua Rupprecht. The company's owners include Bo Jesper Hansen, Jan Struve and MK VENTURES ApS. The company has 9 employees (2026). In 2025, the company reported revenue of DKK 1,616,000 and a net result of DKK -37,626,000 compared with DKK -45,058,000 the year before. Equity in the 2025 report amounted to DKK 12,048,000.

Source: annual report 2025, Danish Business Authority